Vitamin D status is linked to bone health, immune function, and a range of metabolic processes. In northern latitudes, low sun exposure...

Semaglutide and tirzepatide are newer medications used in the treatment of obesity and type 2 diabetes. Both act on incretin pathways that influence appetite, satiety, and glucose regulation. They have generated strong interest because of meaningful effects on body weight and metabolic risk factors in clinical trials. This article reviews the current evidence, typical clinical considerations, and practical issues that arise when these therapies are discussed with patients. Ba